Therapeutic drug monitoring of clozapine and norclozapine in human serum using ultra-performance liquid chromatography-tandem mass spectrometry

Journal of Analytical Toxicology

Volumn 33, Issue 4, 2009, Pages 198-203

  Dong, Sheng Ming ^a   Heathcote, John ^a  

^a BC Biomedical Laboratories Ltd   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM HYDROXIDE; CLOZAPINE; NORCLOZAPINE;

ACCURACY; ARTICLE; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG STABILITY; DRUG STRUCTURE; ELECTROSPRAY; FLOW RATE; FREEZING; HUMAN; LIQUID CHROMATOGRAPHY; PRECIPITATION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; THAWING; THERMOSTABILITY;

EID: 66349092495     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/33.4.198     Document Type: Article

References (23)

1. R.J. Baldessarini and F.R. Frankenburg. Clozapine: a novel anti-psychotic agent. N. Engl. J. Med. 324: 746-754 (1991).
2. S.A. Volpicelli, F. Centorrino, P.R. Puopolo, J. Kando, F.R. Frankenburg, R.J. Baldessarini, and J.G. Flood. Determination of clozapine, norclozapine, and clozapine N-oxide in serum by liquid chromatography. Clin. Chem. 39: 1658-1659 (1993).
3. M. Aravagiri and S.R. Marder. Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients. J. Pharm. Biomed. Anal. 26: 301-311 (2001).
4. H. Hippius. A historical perspective of clozapine. J. Clin. Psychiatry 60(suppl 12): 22-23 (1999).
5. D. Healy. The Creation of Psychopharmacology. Harvard University Press, Cambridge, MA, 2004, pp 238-242.
6. K. Wahlbeck, M. Cheine, A. Essali, and C. Adams. Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am. J. Psychiatry 156: 990-999 (1999).
7. C. Wallis and J. Willwerth. Awakenings schizophrenia. A new drug brings patients back to life. Time July 6, 1992.
8. J.M. Alvir, J.A. Lieberman, A.Z. Safferman, J.L. Schwimmer, and J.A. Schaaf. Clozapine-induced agranulocytosis. Incidence and risk in the United States. N. Engl. J. Med. 329: 162-167 (1993).
9. U.S. Food and Drug Administration. FDA Talk Paper, T02-57, 2002.
10. S. Lawrie, A. McIntosh, and Z. Nadeem. Schizophrenia. Clin. Evid. 8: 1019-1049 (2002).
11. Z. Nadeem, A. McIntosh, and S. Lawrie. Schizophrenia. Clin. Evid. 10: 1208-1233 (2003).
12. A. McIntosh and S. Lawrie. Schizophrenia. Clin. Evid. 12: 1502-1533 (2004).
13. D.C. Goff, E. Halpern, C.B. Saper, and S.L. Rauch. Schizophrenia. Med. Clin. North Am. 85: 663-689 (2001).
14. J. Wong and N. Delva. Clozapine-induced seizures: recognition and treatment. Can. J. Psychiatry 52: 457-463 (2007).
15. M. Kluge, A. Schuld, A. Schacht, H. Himmerich, M.A. Dalal, P.M. Wehmeier, D. Hinze-Selch, T. Kraus, R.W. Dittmann, and T. Pollmächer. Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology 34(1): 118-128 (2009).
16. E. Koller, B. Schneider, K. Bennett, and G. Dubitsky. Clozapineassociated diabetes. Am. J. Med. 111: 716-723 (2001).
17. H.Y. Lane, Y.C. Chang, W.H. Chang, S.K. Lin, Y.T. Tseng, and M.W. Jann. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics. J. Clin. Psychiatry 60: 36-40 (1999).
18. Y.Y. Liu, L.J.A.E. Doude van Troostwijk, and H.-J. Guchelaar. Simultaneous determination of clozapine, norclozapine and clozapine-N-oxide in human plasma by high performance liquid chromatography with ultraviolet detection. Biomed. Chromatogr. 15: 280-286 (2001).
19. M.W. Jann, S.R. Grimley, E.C. Gray, and W.H. Chang. Pharmacokinetics and pharmacodynamics of clozapine. Clin. Pharmacokinet. 24: 161-176 (1993).
20. V. Fischer, J.A. Haar, L. Greiner, R.V. Lloid, and R.P. Mason. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis. Mol. Pharmacol. 40: 846-853 (1991).
21. K. Richter. Determination of clozapine in human serum by capillary gas chromatography. J. Chromatogr. 434: 465-468 (1988).
22. H.A.G. Niederlander, E.H.M. Koster, M.J. Hilhors, H.J. Metting, M. Eilders, B. Ooms, and G.J. de Jong. High throughput therapeutic drug monitoring of clozapine and metabolites in serum by on-line coupling of solid phase extraction with liquid chromatography mass spectrometry. J. Chromatogr. B 834: 98-107 (2006).
23. Z.L. Zhou, X. Li, K.Y. Li, Z.H. Xie, Z.E. Cheng, W.X. Pen, F. Wang, R.H. Zhu, and H.D. Li. Simultaneous determination of clozapine, olanzapine, risperidone and quetiapine in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B 802: 257-262 (2004).